Catalyst
Slingshot members are tracking this event:
Phase 2 Data due in Q1 2018 for Protalix' (PLX) OPRX-106 in Ulcerative Colitis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PLX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 02, 2018
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-newsArticle&ID=2324351
Related Projects
- Potential for Protalix' (PLX) OPRX-106 in Ulcerative Colitis, and What to Expect from Phase 2 Data PLX Execute By: Mar 31, 2017
Related Keywords
Phase 2, Data Release, Ulcerative Colitis, Oprx-106
